Detalles de la búsqueda
1.
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis.
N Engl J Med
; 388(20): 1853-1862, 2023 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37195941
2.
Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis.
N Engl J Med
; 370(24): 2295-306, 2014 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24918373
3.
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
Ann Rheum Dis
; 76(1): 88-95, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27689735
4.
A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis.
Br J Clin Pharmacol
; 82(1): 129-38, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26909489
5.
Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib.
BMC Musculoskelet Disord
; 16: 26, 2015 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886874
6.
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study.
BMC Musculoskelet Disord
; 15: 177, 2014 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24884454
7.
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients.
Arthritis Rheumatol
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38481002
8.
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors.
Ann Rheum Dis
; 72(9): 1461-8, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23268367
9.
Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.
Arthritis Rheum
; 63(3): 622-32, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21360491
10.
Preventive care: vaccines matter.
Am J Manag Care
; 27(7): 269-270, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34314113
11.
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
J Rheumatol
; 48(8): 1230-1238, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33526618
12.
Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates.
South Med J
; 102(5): 486-92, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19373149
13.
Hearing Loss As A Surrogate Marker For Early Atherosclerosis in A High-Risk Population: A Prospective Study.
Am J Cardiol
; 211: 191-192, 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37949343
14.
FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension.
Arthritis Res Ther
; 21(1): 281, 2019 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31831079
15.
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.
Rheumatol Ther
; 6(4): 503-520, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31410787
16.
Biosimilars Have Arrived: Rituximab.
Arthritis
; 2018: 3762864, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29765782
17.
Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis.
Rheumatol Ther
; 5(1): 43-55, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29680881
18.
Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.
RMD Open
; 4(1): e000662, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29765703
19.
A mode of error: Immunoglobulin binding protein (a subset of anti-citrullinated proteins) can cause false positive tuberculosis test results in rheumatoid arthritis.
J Clin Tuberc Other Mycobact Dis
; 9: 5-9, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31723711
20.
Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.
Arthritis Rheumatol
; 69(5): 932-942, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28118538